China’s biotech Vcanbio launches US subsidiaries

September 22, 2016    By The Pharma Letter

Vcanbio Cell & Gene Engineering Corp (SSE: 600645), which claims to be China’s largest biotechnology company, has expanded its horizon by opening an office in the USA.

Vcanbio USA and Vcanbio Center for Translational Biotechnology (VCANBIO CTB) have hosted an opening ceremony to celebrate the launch of US operations as subsidiaries of the parent firm, a company focused on cell therapy and precision medicine, both located in Natick, Massachusetts…….Read full article from The Pharma Letter